On April 17, 2023, Exelixis, Inc. filed a preliminary proxy statement soliciting proxies and urged the shareholders to vote for the election of its board nominees: Maria C. Freire, Alan M. Garber, Michael M. Morrissey, Stelios Papadopoulos, George Poste, Julie Anne Smith, Lance Willsey, Jacqueline Wright, Jack L. Wyszomierski and for the election of Farallon Capital Management, L.L.C. nominees recommended by the Company Board of Directors: Tomas J. Heyman and Robert âBobâ Oliver, withhold on the election of the non-recommended Farallon Capital Management nominee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.12 USD | +0.62% | -2.18% | -11.96% |
05-14 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
05-10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.96% | 6.11B | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis Solicits Proxies from Shareholders